Strados Labs Announces New Partnership with Trialogics!

Learn More

HEALTHCARE & REMOTE PATIENT MONITORING

RESP® Biosensor

Manage lung health from hospital to home with objective, real-time monitoring of symptoms

FDA 510(k) Class II Device | CE Mark | HIPAA Compliant

cough monitoring RESP biosensor

Technology Overview

Developed by an asthma patient, the RESP® Biosensor offers clinicians a better way to manage chronic respiratory diseases and help break the cycle of readmissions for patients.

  • Continuous lung sound monitoring: wearable device passively captures adventitious lung sounds such as cough, wheeze and crackles.
  • Patient-friendly device: Wireless, discreet design that respects patient comfort and lifestyle.
  • Earlier notice of exacerbations: Allows clinicians to remotely detect early signs of deterioration and adjust treatment plans.
Strados Cough Monitoring Solution

Track Patient Progress Objectively and Remotely

Patient reports include accurate, time-stamped data on signs and symptoms such as coughing and wheezing, allowing for greater diagnostics and insight into treatment response.

The Strados Difference

LUNG ACOUSTICS

The primary distinction between our device and standard of care is our ability to extend the range of the stethoscope. Abnormal lung sounds such as cough, wheeze, rhonchi, and crackles can indicate various respiratory issues, including airway obstruction, fluid accumulation, inflammation, or bronchospasm. These sounds often offer the earliest signs of respiratory distress or disease exacerbation.

KEY FEATURES

  • Passive & continuous
  • Patient-friendly: non-invasive and unobtrusive
  • HIPAA compliant: privacy-preserving and end-to-end encryption
  • Reimbursable under RTM & RPM codes
  • 24+ hour battery life and rechargeable
  • EHR/telehealth integration
  • Supported by proprietary machine learning algorithms

Addressing Gaps in Traditional Standard of Care

Pulmonary Function Tests

  • Episodic
  • Patient-effort dependent
  • Not used to predict exacerbations

Patient
E-Diaries

  • Prone to misinformation and inconsistency
  • Limited clinical utility
  • Relies on patient effort and recall

Pulse
Oximetry

  • Limited insight into respiratory system
  • Less sensitive in detecting early, sudden changes

RESP® Biosensor

  • Objective and continuous
  • Comprehensive respiratory data
  • Enables earlier detection of exacerbations

RESP® Biosensor Care Settings and Applications

Ambulatory Care

 

  • Remote monitoring of at-risk COPD & Asthma patients
  • Interstitial lung diseases
  • Heart failure
  • Pulmonary Rehabilitation

Acute Care

 

  • In-patient status monitoring
  • Chronic, complex care management
  • Hospital at Home
  • Tele-ICUs

Post-Acute Care

 

  • Post-discharge hospital to home
  • Post-surgical recovery and rehabilitation
  • Skilled-nursing and long-term care facilities

Patient Journey Example

At-risk COPD patient is discharged from hospital

Patient is prescribed RESP®  Biosensor for two weeks

On day 5, clinician receives  alert of increased coughing and wheezing

Clinician checks in with patient virtually and adjusts treatment plan to avoid a readmission

OVERVIEW VIDEO

“With this information we can predict if the patient is doing better or worse and intervene ahead of time to prevent the patient having major complications”

– Sadia Benzaquen, MD, Chair of Pulmonary Critical Care, Einstein Medical Center

Let’s Talk

We’d love to know how we can help you and your patients.